activity
20192023
most citedPossible Contexts of Use for In Silico trials methodologies: a consensus-based review

64 citations · 74 across the 7 of their papers we have counts for

collaborators

7 papers

physics.med-ph2023★ 2 cited

From the digital twins in healthcare to the Virtual Human Twin: a moon-shot project for digital health research

Marco Viceconti, Maarten De Vos, Sabato Mellone +1

The idea of a systematic digital representation of the entire known human pathophysiology, which we could call the Virtual Human Twin, has been around for decades. To date, most re…

physics.bio-ph2021★ 64 cited

Possible Contexts of Use for In Silico trials methodologies: a consensus-based review

Marco Viceconti, Luca Emili, Payman Afshari +15

The term "In Silico Trial" indicates the use of computer modelling and simulation to evaluate the safety and efficacy of a medical product, whether a drug, a medical device, a diag…

q-bio.QM2021★ 1 cited

Verification of an agent-based disease model of human mycobacterium tuberculosis infection

Cristina Curreli, Francesco Pappalardo, Giulia Russo +5

Agent-Based Models are a powerful class of computational models widely used to simulate complex phenomena in many different application areas. However, one of the most critical asp…

q-bio.QM2020

In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform

Giulia Russo, Marzio Pennisi, Marco Viceconti +1

SARS-CoV-2 is a severe respiratory infection that infects humans. Its outburst entitled it as a pandemic emergence. To get a grip on this, outbreak specific preventive and therapeu…

q-bio.QM2019

Generation of digital patients for the simulation of tuberculosis with UISS-TB

Marzio Pennisi, Miguel A. Juarez, Giulia Russo +2

EC funded STriTuVaD project aims to test, through a phase IIb clinical trial, two of the most advanced therapeutic vaccines against tuberculosis. In parallel, we have extended the…

q-bio.QM2019

Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator

Giulia Russo, Francesco Pappalardo, Miguel A. Juarez +5

Tuberculosis (TB) is one of the deadliest diseases worldwide, with 1,5 million fatalities every year along with potential devastating effects on society, families and individuals.…